Social media and pharmacovigilance: A review of the opportunities and challenges

British Journal of Clinical Pharmacology

Volumn 80, Issue 4, 2015, Pages 910-920

  Sloane, Richard ^a   Osanlou, Orod ^a,b   Lewis, David ^c   Bollegala, Danushka ^a   Maskell, Simon ^a   Pirmohamed, Munir ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

adverse drug reactions; pharmacovigilance; signal generation; social media

Indexed keywords

ARTICLE; DATA MINING; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; ETHICS; HUMAN; MACHINE LEARNING; PRIORITY JOURNAL; SOCIAL MEDIA; SOCIAL NETWORK; SOCIAL SUPPORT; STATISTICS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; UTILIZATION;

DATA MINING; DRUG INDUSTRY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PHARMACOVIGILANCE; SOCIAL MEDIA;

EID: 84942551481     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12717     Document Type: Article

References (96)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM,. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9.
2. MHRA. Trends in UK spontaneous Adverse Drug Reaction (ADR) reporting between 2008-2012 [Internet]. MHRA; 2014. Available at http://webarchive.nationalarchives.gov.uk/20141205150130/http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con408250.pdf (last accessed 1 June 2015).
3. Pew Research Center: Internet ST. Health Online 2013 [Internet]. Pew Research Center; 2015. Available at http://www.pewinternet.org/2013/01/15/health-online-2013/ (last accessed 1 June 2015).
4. Statistica. Number of monthly active Twitter users worldwide from 1st quarter 2010 to 1st quarter 2015 [Internet]. Statistica; 2015. Available at http://www.statista.com/statistics/282087/number-of-monthly-active-twitter-users/ (last accessed 1 June 2015).
5. Statistica. Number of monthly active Facebook users worldwide from 1st quarter 2010 to 1st quarter 2015 [Internet]. Statistica; 2015. Available at http://www.statista.com/statistics/264810/number-of-monthly-active-facebook-users-worldwide/ (last accessed 1 June 2015).
6. Twitter. Welcome to Twitter [Internet]. Twitter; 2015. Available at https://twitter.com/ (last accessed 1 June 2015).
7. Facebook. Facebook [Internet]. Facebook; 2015. Available at https://www.facebook.com / (last accessed 1 June 2015).
8. Sakaki T, Okazaki M, Matsuo Y,. Earthquake shakes Twitter users: real-time event detection by social sensors. In: Proceedings of the 19th international conference on World wide web. Raleigh, North Carolina, USA: ACM, 2010; 851-60.
9. Chunara R, Andrews JR, Brownstein JS,. Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak. Am J Trop Med Hyg 2012; 86: 39-45.
10. Nikfarjam A, Gonzalez GH,. Pattern mining for extraction of mentions of adverse drug reactions from user comments. In: AMIA Annual Symposium Proceedings: American Medical Informatics Association, 2011: 1019-1026.
11. Chee BW, Berlin R, Schatz B,. Predicting adverse drug events from personal health messages. In: AMIA Annual Symposium Proceedings: American Medical Informatics Association, 2011: 217-26.
12. Yang CC, Yang H, Jiang L, Zhang M,. Social media mining for drug safety signal detection. In: Proceedings of the 2012 international workshop on Smart health and wellbeing: ACM, 2012: 33-40.
13. Liu X, Chen H,. AZDrugMiner: an information extraction system for mining patient-reported adverse drug events in online patient forums. Smart Health: Springer, 2013; 134-50.
14. Liu X, Liu J, Chen H,. Identifying Adverse Drug Events from Health Social Media: A Case Study on Heart Disease Discussion Forums. Smart Health: Springer, 2014; 25-36.
15. Patki A, Sarker A, Pimpalkhute P, Nikfarjam A, Ginn R, O'Connor K, Smith K, Gonzalez G,. Mining adverse drug reaction signals from social media: going beyond extraction. Proceedings of BioLinkSig 2014; 2014: 1-8.
16. Yang CC, Yang H, Jiang L,. Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media. ACM Trans Mgt Inf Sys 2014; 5: Article 2, 21 pages.
17. Sampathkumar H, Chen XW, Luo B,. Mining adverse drug reactions from online healthcare forums using hidden Markov model. BMC Med Inform Decis Mak 2014; 14: 91. 1-18.
18. Knezevic MZ, Bivolarevic IC, Peric TS, Jankovic SM,. Using Facebook to increase spontaneous reporting of adverse drug reactions. Drug Saf 2011; 34: 351-2.
19. Bian J, Topaloglu U, Yu F,. Towards large-scale twitter mining for drug-related adverse events. Association for Computing Machinery. Proceedings of the 2012 international workshop on Smart health and wellbeing 2012: 25-32.
20. Jiang K, Zheng Y,. Mining twitter data for potential drug effects. In: Advanced Data Mining and Applications, eds, Motoda H, Wu Z, Cao L, Zaiane O, Yao M, Wang W,. Berlin Heidelberg: Springer, 2013; 8346: 434-43.
21. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, Dasgupta N,. Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Drug Saf 2014; 37: 343-50.
22. Ginn R, Pimpalkhute P, Nikfarjam A, Patki A, O'Connor K, Sarker A, Gonzalez G,. Mining Twitter for adverse drug reaction mentions: a corpus and classification benchmark. LREC BioTexM. Proceedings of the fourth workshop on building and evaluating resources for health and biomedical text processing, 2014; 2: 1-8.
23. O'Connor K, Pimpalkhute P, Nikfarjam A, Ginn R, Smith KL, Gonzalez G,. Pharmacovigilance on Twitter? Mining Tweets for adverse drug reactions. AMIA Annual Symposium Proceedings: American Medical Informatics Association, 2014: 924-933.
24. Sarker A, Gonzalez G,. Portable automatic text classification for adverse drug reaction detection via multi-corpus training. J Biomed Inform 2015; 53: 196-207.
25. Nikfarjam A, Sarker A, O'Connor K, Ginn R, Gonzalez G,. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features. J Am Med Inform Assoc 2015; 22: 671-82.
26. Benton A, Ungar L, Hill S, Hennessy S, Mao J, Chung A, Leonard CE, Holmes JH,. Identifying potential adverse effects using the web: A new approach to medical hypothesis generation. J Biomed Inform 2011; 44: 989-96.
27. Hadzi-Puric J, Grmusa J,. Automatic drug adverse reaction discovery from parenting websites using disproportionality methods. Proceedings of the 2012 International Conference on Advances in Social Networks Analysis and Mining (ASONAM 2012): IEEE Computer Society, 2012: 792-97.
28. Yates A, Goharian N,. ADRTrace: detecting expected and unexpected adverse drug reactions from user reviews on social media sites. In: Advances in Information Retrieval, eds, Serdyukov P, Braslavski P, Kuznetsov S, Kamps J, Rüger S, Agichtein E, Segalovich I, Yilmaz E,. Berlin Heidelberg: Springer-Verlag, 2013; 7814: 816-19.
29. Yeleswarapu S, Rao A, Joseph T, Saipradeep VG, Srinivasan R,. A pipeline to extract drug-adverse event pairs from multiple data sources. BMC Med Inform Decis Mak, 2014; 14: 13.
30. Segura-Bedmar I, Revert R, Martínez P,. Detecting drugs and adverse events from Spanish health social media streams. Proceedings of the 5th International Workshop on Health Text Mining and Information Analysis (Louhi), EACL, April 2014: 106-15.
31. Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G,. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. Proceedings of the 2010 Workshop on Biomedical Natural Language Processing, Uppsala, Sweden: Association for Computational Linguistics, 2010: 117-25.
32. Patientslikeme. Patientslikeme [Internet]. Patientslikeme; 2015. Available at https://www.patientslikeme.com / (last accessed 1 June 2015).
33. DailyStrength. Online Support Groups and Forums at DailyStrength [Internet]. DailyStrength; 2015. Available at http://www.dailystrength.org (last accessed 1 June 2015).
34. MedHelp. All Ask a Doctor Forums and Medical Commmunities-MedHelp [Internet]. MedHelp; 2015. Available at http://www.medhelp.org/forums/list (last accessed 1 June 2015).
35. Sarker A, Ginn R, Nikfarjam A, O'Connor K, Smith K, Jayaraman S, Upadhaya T, Gonzalez G,. Utilizing social media data for pharmacovigilance: A review. J Biomed Inform 2015; 54: 202-12.
36. Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, Jung K, LePendu P, Shah NH,. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf 2014; 37: 777-90.
37. Pimpalkhute P, Patki A, Nikfarjam A, Gonzalez G,. Phonetic spelling filter for keyword selection in drug mention mining from social media. AMIA Summits Trans Sci Proc 2014; 2014: 90-95.
38. Bollegala D, Matsuo Y, Ishizuka M,. Automatic discovery of personal name aliases from the web. IEEE Trans Knowledge Data Eng 2011; 23: 831-44.
39. Food and Drugs Administration. FDA Adverse Event Reporting System (FAERS) [Internet]. Food and Drugs Administration. Available at http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm (last accessed 1 June 2015).
40. COSTART. Coding Symbols for a Thesaurus of Adverse Reaction Terms-Summary [Internet]. NCBO BioPortal; 2015. Available at http://bioportal.bioontology.org/ontologies/COSTART (last accessed 1 June 2015).
41. Initiative CHV. Open Access, Collaborative Consumer Health Vocabulary Initiative [Internet]. Available at http://www.consumerhealthvocab.org / (last accessed 1 June 2015)
42. Medeffect Canada. MedEffect Canada [Internet]. Health Canada; 2015. Available at http://www.hc-sc.gc.ca/dhp-mps/medeff/index-eng.php (last accessed 1 June 2015).
43. UMLS. Unified Medical Language System® (UMLS®) [Internet]. US National Library of Medicine; 2015. Available at http://www.nlm.nih.gov/research/umls/ (last accessed 1 June 2015).
44. MedDRA. Welcome to MedDRA [Internet]. MedDRA. Available at http://www.meddra.org (last accessed 1 June 2015).
45. SIDER. SIDER Side Effect Resource [Internet]. SIDER; 2012. Available at http://sideeffects.embl.de (last accessed 1 June 2015).
46. Yang M, Kiang M, Shang W,. Filtering big data from social media-Building an early warning system for adverse drug reactions. J Biomed Inform 2015; 54: 230-40.
47. Zhang C, Chen T,. An active learning framework for content-based information retrieval. IEEE Trans Multimedia 2002; 4: 260-68.
48. Bollegala D, Kontonatsios G, Ananiadou S,. A cross-lingual similarity measure for detecting biomedical term translations. PLoS One 2015; 10 e0126196. doi: 10.1371/journal.pone.0126196.
49. Hauben M, Zhou X,. Quantitative methods in pharmacovigilance. Drug Saf 2003; 26: 159-86.
50. Hazell L, Shakir SA,. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29: 385-96.
51. de Boissieu P, Kanagaratnam L, Abou Taam M, Roux MP, Drame M, Trenque T,. Notoriety bias in a database of spontaneous reports: the example of osteonecrosis of the jaw under bisphosphonate therapy in the French national pharmacovigilance database. Pharmacoepidemiol Drug Saf 2014; 23: 989-92.
52. Moore N, Hall G, Sturkenboom M, Mann R, Lagnaoui R, Begaud B,. Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol Drug Saf 2003; 12: 271-81.
53. Nguyen D, Gravel R, Trieschnigg D, Meder T,. " How old do you think I am?" A study of language and age in Twitter. Proceedings of the Seventh International AAAI Conference on Weblogs and Social Media: AAAI Press, 2013; 439-48.
54. Mislove A, Lehmann S, Ahn Y-Y, Onnela J-P, Rosenquist JN,. Understanding the demographics of Twitter Users. ICWSM 2011; 11: 5. 1-4.
55. Huang J, Gretton A, Borgwardt KM, Schölkopf B, Smola AJ,. Correcting sample selection bias by unlabeled data. Advances in neural information processing systems, 2006: 601-08.
56. Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA,. Enrolling pregnant women: issues in clinical research. Womens Health Issues 2013; 23: 39-45.
57. Field M, Berman R,. Institute of Medicine (US). Committee on Clinical Research Involving Children. Ethical conduct of clinical research involving children. Eds, Field M, Berman R,. Washington, DC: National Academies Press, 2004.
58. Pew Research Center: Internet ST. Demographics of key social networking platforms. [Internet]. Pew Research Center; 2013. Available at http://www.pewinternet.org/2013/12/30/demographics-of-key-social-networking-platforms/ (last accessed 1 June 2015).
59. Yang J-B, Xu D-L,. Evidential reasoning rule for evidence combination. Artif Intell 2013; 205: 1-29.
60. Kim YA, Ahmad MA,. Trust, distrust and lack of confidence of users in online social media-sharing communities. Know-Based Syst 2013; 37: 438-50.
61. Harpaz R, Vilar S, Dumouchel W, Salmasian H, Haerian K, Shah NH, Chase HS, Friedman C,. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J Am Med Inform Assoc 2013; 20: 413-9.
62. Harpaz R, DuMouchel W, LePendu P, Shah NH,. Empirical bayes model to combine signals of adverse drug reactions. In: Proceedings of the 19th ACM SIGKDD international conference on knowledge discovery and data mining. Chicago, Illinois, USA: ACM, 2013; 1339-47.
63. LinkedIn. Join the world's largest professional network [Internet]. LinkedIn; 2015. Available at https://www.linkedin.com/nhome/ (last accessed 1 June 2015).
64. YouTube. YouTube GB [Internet]. Google; 2015. Available at https://www.youtube.com / (last accessed 1 June 2015).
65. Flipboard. Flipboard is Your Personal Magazine [Internet]. Flipboard; 2015. Available at https://flipboard.com / (last accessed 1 June 2015).
66. Flickr. The home for all your photos. [Internet]. Yahoo; 2015. Available at https://www.flickr.com / (last accessed 1 June 2015).
67. Pinterest. What's Pinterest? [Internet]. Pinterest; 2015. Available at https://about.pinterest.com/en-gb (last accessed 1 June 2015).
68. Twitter. Pharmaceutical News (@PharmaIQ) on Twitter [Internet]. Twitter. Available at https://twitter.com/pharmaiq (last accessed 1 June 2015).
69. Twitter. Novartis (@Novartis) on Twitter [Internet]. Twitter. Available at https://twitter.com/novartis (last accessed 1 June 2015).
70. Twitter. Pfizer Inc. (@pfizer) on Twitter [Internet]. Twitter. Available at https://twitter.com/pfizer (last accessed 1 June 2015).
71. Twitter. Roche (@Roche) on Twitter [Internet]. Twitter. Available at https://twitter.com/roche (last accessed 1 June 2015).
72. ICH Expert Working Group. ICH Harmonised Tripartite Guideline. Clinical safety data management: definitions and standards for expedited reporting E2A. European Medicines Agency. 27 October 1994. Available at http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E2A/Step4/E2A-Guideline.pdf (last accessed 1 June 2015).
73. Edwards IR, Lindquist M,. Social media and networks in pharmacovigilance: boon or bane? Drug Saf 2011; 34: 267-71.
74. European Commission. Commission Implementing Regulation 520/2012. Off J Eur Union 2012; 55: 5-25. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:159:0005:0025:EN:PDF (last accessed 1 June 2015).
75. European Commission. Directive 2001/83/EC of the European Parliament and of the Council. Official J Eur Comm 2001; 44: 67-128. Available at http://www.edctp.org/fileadmin/documents/ethics/DIRECTIVE-200183EC-OF-THE-EUROPEAN-PARLIAMENT.pdf (last accessed 1 June 2015).
76. European Commission. Regulation 726/2004. Off J Eur Union 2010; 47: 1-33. Available at http://ec.europa.eu/health/files/eudralex/vol-1/reg-2004-726/reg-2004-726-en.pdf (last accessed 1 June 2015).
77. European Medicines Agency. Good Pharmacovigilance Practices, Module VI, Revision 1, Management and reporting of adverse reactions to medicinal products. EMA/873138/2011. 08/09/2014. Available at http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/09/WC500172402.pdf (last accessed 1 June 2015).
78. Food and Drugs Administration. Draft guidance: Internet/Social Media Platforms with Character Space Limitations-Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices. [Internet]. Food and Drugs Administration; June 2014. Available at http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm401087.pdf (last accessed 1 June 2015).
79. Food and Drugs Administration. Draft guidance: Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices. [Internet]. Food and Drugs Administration; June 2014. Available at http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm401079.pdf (last accessed 1 June 2015).
80. Food and Drugs Administration. Inspections, Compliance, Enforcement, and Criminal Investigations. Zarbee's, Inc. [Internet]. Food and Drugs Administration; 2014. Available at http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2014/ucm403255.htm (last accessed 1 June 2015).
81. Food and Drugs Administration. Tirosint letter [Internet]. Food and Drugs Administration; 2014. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM388800.pdf (last accessed 1 June 2015).
82. Nielsen. Listening to consumers in a highly regulated environment. How pharmaceutical manufacturers can leverage consumer-generated media. [Internet]. The Nielsen Company; August 2008. Available at http://www.nielsen.com/content/dam/corporate/us/en/newswire/uploads/2009/11/Nielsen-Online-Healthcare-Practice-Social-Media-Adverse-Event-Reporting-nov09.pdf (last accessed 1 June 2015).
83. Barnard-Wills D,. UK news media discourses of surveillance. Sociol Quarterly 2011; 52: 548-67.
84. Swirsky ES, Hoop JG, Labott S,. Using social media in research: new ethics for a new meme? Am J Bioeth 2014; 14: 60-1.
85. Taylor HA, Kuwana E, Wilfond BS,. Ethical implications of social media in health care research. Am J Bioeth 2014; 14: 58-9.
86. Financial Ombudsman Service. Ombudsman News. [Internet]. Financial Ombudsman Service; May/June 2005. Issue 46. Available at http://www.financial-ombudsman.org.uk/publications/ombudsman-news/46/46.pdf (last accessed 1 June 2015).
87. Farnan JM,. Connectivity and consent: does posting imply participation? Am J Bioeth 2014; 14: 62-3.
88. Department for Transport. Drug drive legislation: am I fit to drive? [Internet]. UK Government; February 2015. Available at https://www.gov.uk/government/news/drug-drive-legislation-am-i-fit-to-drive (last accessed 1 June 2015).
89. Kress HG, Kraft B,. Opioid medication and driving ability. Eur J Pain 2005; 9: 141-44.
90. Kailasam VK, Samuels E,. Can social media help mental health practitioners prevent suicides? Anecdotal evidence suggests that analyzing Facebook posts can lead to earlier intervention. Curr Psych 2015; 14: 37-51.
91. Pandian PS, Mohanavelu K, Safeer KP, Kotresh TM, Shakunthala DT, Gopal P, Padaki VC,. Smart Vest: wearable multi-parameter remote physiological monitoring system. Med Eng Phys 2008; 30: 466-77.
92. Yilmaz T, Foster R, Hao Y,. Detecting vital signs with wearable wireless sensors. Sensors 2010; 10: 10837-62.
93. Bandodkar AJ, Wang J,. Non-invasive wearable electrochemical sensors: a review. Trends Biotechnol 2014; 32: 363-71.
94. Simmering JE, Polgreen LA, Polgreen PM,. Web search query volume as a measure of pharmaceutical utilization and changes in prescribing patterns. Res Social Adm Pharm 2014; 10: 896-903.
95. WEB-RADR. WEB-RADR: Recognising adverse drug reactions. [Internet]. WEB-RADR; 2015. Available at http://web-radr.eu / (last accessed 1 June 2015).
96. Sukkar E,. Searching social networks to detect adverse events. Pharmaceut J 2015; 294: 75-78.